Journal
INFLAMMATORY BOWEL DISEASES
Volume 27, Issue 5, Pages 662-666Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/ibd/izaa162
Keywords
Coronavirus; SARS-CoV-2; COVID-19; inflammatory bowel disease
Categories
Ask authors/readers for more resources
This case series study found that severe outcomes of COVID-19 after infection in patients with IBD were rare, and comparable to similarly aged individuals in the general population.
Background: We aimed to characterize patients with inflammatory bowel disease (IBD) and novel coronavirus disease 2019 (COVID-19). Methods: We performed a case series of patients with IBD and confirmed or highly suspected COVID-19 to assess rates of severe outcomes. Results: We identified 83 patients with IBD with confirmed (54%) or highly suspected (46%) COVID-19. The overall hospitalization rate was 6%, generally comprising patients with active Crohn's disease or older men with comorbidities, and 1 patient expired. Discussion: In this series of patients with IBD, severe outcomes of COVID-19 were rare and comparable to similarly aged individuals in the general population.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available